In summary, our findings establish the dysregulated ER response etiology for adverse myocardial inflammation via HMGB1, also supporting treatment strategies for preventing DCM by reducing the pro-inflammatory paracrine signal from cardiomyocytes. Here, HMGB1 is linked to familial dilated cardiomyopathy.